Neuroprotective Effect of (Nano PSO), in Patients Who Used to Consume Psychoactive Substances

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 15, 2024

Primary Completion Date

March 30, 2026

Study Completion Date

March 15, 2027

Conditions
Addiction;Drug(S);LSDNeuroprotective
Interventions
DIETARY_SUPPLEMENT

Nano-PSO, Pomegranate seed oil (omega-5)

"During the intervention, Nano-PSO dietary supplement will be administered to the participants in the assigned group.~Participants will be followed before and after treatment to assess the effects of Nano-PSO on cognitive status, serum concentrations of trophic factors, and other relevant parameters . This randomized, double-blind, controlled clinical trial design allows for a rigorous evaluation of the potential benefits of Nano-PSO in patients with substance use disorders. The study aims to provide valuable insights into the neuroprotective and cognitive-enhancing properties of Nano-PSO in this population."

OTHER

PLACEBO

In this arm of the study the participants will receive a placebo as a control treatment . The placebo is essential in clinical trials to compare the effects of the active intervention (Nano-PSO) with those of an inert substance.

Trial Locations (1)

Unknown

RECRUITING

Irene Guadalupe Aguilar García PhD., Guadalajara

All Listed Sponsors
lead

Distribuidora Biolife SA de CV

INDUSTRY